PELOBiotech GmbH, a leader in the field of biotechnology, announces a strategic partnership with HVD Life Science Vertriebs GmbH to distribute the innovative Poietis’ Next-Gen Bioprinting platform, NGB-RTM in Germany.
This strategic partnership is anticipated to set new standards in the field of biotechnological research, providing scientists and researchers in Germany with access to state-of-the-art bioprinting technology. The Poietis’ NGB-R™ platform is expected to play a crucial role in advancing research in tissue engineering, regenerative medicine, and drug discovery, among other areas.